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Abstract
Using animal models of alcoholism, previous studies suggest that neuropeptide Y (NPY) may be 
implicated in alcohol preference and consumption due to its role in the modulation of feeding and 
anxiety. Quantitative trait loci (QTL) analysis previously identified an interval on rat chromosome 
4 that is highly associated with alcohol preference and consumption using an F2 population 
derived from inbred alcohol-preferring (iP) and -nonpreferring (iNP) rats. NPY mapped to the 
peak of this QTL region and was prioritized as a candidate gene for alcohol-seeking behavior in 
the iP and iNP rats. In order to identify a potential mechanism for reduced NPY protein levels 
documented in the iP rat, genetic and molecular components that influence NPY expression were 
analyzed between iP and iNP rats. Comparing the iP rat to the iNP rat, quantitative real-time 
polymerase chain reaction detected significantly decreased levels of NPY mRNA expression in 
the iP rat in the six brain regions tested: nucleus accumbens, frontal cortex, amygdala, 
hippocampus, caudate-putamen, and hypothalamus. In addition, the functional significance of 
three previously identified polymorphisms was assessed using in vitro expression analysis. The 
polymorphism defined by microsatellite marker D4Mit7 in iP rats reduced luciferase reporter gene 
expression in SK-N-SH neuroblastoma cells. These results suggest that differential expression of 
the NPY gene resulting from the D4mit7 marker polymorphism may contribute to reduced levels 
of NPY in discrete brain regions in the iP rats.
Keywords
neuropeptide Y; alcohol preference; selective breeding; mRNA expression; polymorphism; 
quantitative trait locus
Alcoholism is a complex disorder influenced by the interaction between multiple genes and 
the environment, exhibiting a heritability that ranges from 50 to 60% in both men and 
women (Heath et al., 1997). Thus far, however, only the protective effects of the alcohol 
metabolizing enzymes have been consistently replicated (Foroud and Li, 1999; Thomasson 
et al., 1993). To identify genetic factors that influence alcoholism, the alcohol-preferring (P) 
and -nonpreferring (NP) lines were developed from a randomly bred closed colony of Wistar 
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rats through bidirectional selective breeding on the basis of alcohol consumption and 
preference (Li et al., 1991). In this model, P rats display the characteristics that are 
considered necessary for an animal model of alcoholism (Cicero, 1979). Subsequently, 
inbred P (iP) and NP (iNP) strains have been established that maintain highly discordant 
alcohol consumption scores.
Previous studies suggest that neuropeptide Y (NPY) is implicated in the modulation of 
alcohol consumption in P and NP rats (Cowen et al., 2004; Thiele and Badia-Elder, 2003; 
Pandey et al., 2003). P rats display lower levels of NPY immunoreactivity in various regions 
of the brain, including the central nucleus of the amygdala, hippocampus and the frontal 
cortex and higher levels in the paraventricular hypothalamic nucleus and arcuate nucleus of 
the hypothalamus (Ehlers et al., 1998; Hwang et al., 1999). Furthermore, decreased levels of 
NPY are associated with increased anxiety in P rats (Colombo, 1997; Stewart et al., 1993), 
and i.c.v. infusion of NPY has been shown to reduce ethanol intake in the P rat (Gilpin et al., 
2003). NPY is localized to an interval that is highly associated with alcohol preference and 
consumption, mapping to a quantitative trait locus with a lod score of 9.2 on rat 
chromosome 4, using an F2 population bred from iP and iNP rats (Carr et al., 1998; Bice et 
al., 1998).
In addition, mice deficient in NPY exhibit increased alcohol consumption compared with 
wild-type mice, and an over-expression of NPY decreases ethanol consumption in 
transgenic mice (Thiele et al., 1998). In humans, a polymorphism in NPY (Leu7Pro) was 
significantly associated with dependence in European American and Finnish alcoholics, both 
exhibiting an increased frequency of the Pro7 allele compared with controls (Lappalainen et 
al., 2002; Zhu et al., 2003). Therefore, these studies have established NPY as an excellent 
candidate gene for alcoholism and alcohol preference, documenting an inverse relationship 
between NPY levels and alcohol consumption.
While a relationship between NPY and alcohol consumption has been established, the 
molecular and physiological mechanism responsible for this relationship remains to be 
elucidated. Because NPY is likely to function in memory, stress, hypertension, feeding and 
emotion (Heilig and Thorsell, 2002), this study was conducted to better understand the 
genetic and molecular components that influence NPY expression in iP and iNP rats. Thus, 
to further characterize the relationship between NPY and alcohol preference in P and NP 
rats, mRNA expression was evaluated in several brain regions between alcohol-naive iP and 
iNP rats, and transient transfection assays were performed on three previously identified 
polymorphisms (Bice et al., 1998) to determine their functional significance.
EXPERIMENTAL PROCEDURES
Dissection of brain regions
Five iP and four iNP alcohol-naive adult male rats were killed, and the entire brain was 
removed and dissected using the coordinates of Paxinos and Watson (Paxinos and Watson, 
1998) to produce six subregional tissue samples: 1) nucleus accumbens, 2) frontal cortex, 3) 
amygdala, 4) hippocampus, 5) caudate-putamen, and 6) hypothalamus. These subregions 
were selected because they have been implicated in the mesocorticolimbic dopamine 
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system, reciprocally interacting with the VTA to regulate alcohol-drinking behavior 
(McBride and Li, 1998). The nucleus accumbens and caudate putamen are dissected from a 
2 mm section generated by a coronal cut at 2 mm anterior to the optic chiasm (Bregma 1.70 
mm) and a coronal cut at the optic chiasm (Bregma −0.26 mm). The nucleus accumbens is 
dissected bilaterally by cutting below the rhinal fissure and trimming off the olfactory 
tubercles and cortical tissue at the ventral and ventrolateral borders of the slice. From the 
remaining tissue the caudate putamen (bilateral) is dissected below the corpus callosum 
leaving the septum hanging in the center. The hypothalamus is dissected from the tissue 
posterior to the optic chiasm by making an incision 2 mm to both the right and the left of the 
midline and a cut in front of the mammillary bodies as the caudal limit. The amygdala is 
dissected by a cut at the lateral borders of the lateral hypothalamus (Bregma −2.12 mm) and 
ventral of the rhinal fissure, with cortical tissue then removed at the lateral edges of the 
dissected slice. The caudal border of the amygdalar dissection is the rostroventral border of 
the CA3 subfield of Ammon’s horn (−4.16 mm). The entire hippocampus is dissected from 
the remaining brain by a midline incision between the hemispheres and rolling the 
hippocampus out of the cerebral cortex. All of the experiments utilized in this study 
conformed to local and international guidelines on the ethical use of animals in order to 
minimize the number of animals used and their suffering.
Isolation of RNA
The microdissected tissues were snap frozen on dry ice and stored at −80 °C until RNA 
isolation. RNA was isolated according to the RNeasy Midi manufacturer’s protocol (Qiagen, 
Valencia, CA, USA), and the isolated RNA was resuspended in diethyl-pyrocarbonate-
treated water, treated with DNase I, and stored at −80 °C.
Quantitative real-time RT-PCR (polymerase chain reaction)
Using the ABI PRISM 7700 Sequence Detection System (PE Biosystems, Wellesley, MA, 
USA), the relative mRNA expression levels of NPY in the iP and iNP rats were determined 
in the nucleus accumbens, frontal cortex, amygdala, hippocampus, caudate-putamen, and 
hypothalamus by quantitative real-time RT-PCR (qRT-PCR). cDNA was generated from the 
six selected brain regions of each of the five iP and four iNP rats. cDNA template, generated 
from 50 ng total RNA, was added to each PCR reaction that contained 0.1 μM forward and 
reverse primers and SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, 
USA). Each reaction was performed in triplicate. The integrated software package 
accompanying the ABI PRISM 7700 was utilized to select the NPY-1F and NPY-1R 
primers for qRT-PCR (Table 1). The specificity of these primers was confirmed using 
agarose gel analysis. Each sample was amplified for 40 cycles, and the cycle threshold (Ct) 
was determined for each cDNA template. The Ct refers to the cycle number at which the 
fluorescence of the amplified product reached an arbitrary threshold that was within the 
exponential phase of amplification. Relative values of expression were determined for each 
sample using the standard curve method, and these values were normalized to the Ct values 
of GAPDH, a standard “housekeeping” control gene, using glyceraldehyde phosphate 
dehydrogenase (GAPDH)-F and GAPDH-R primers (Table 1) for PCR amplification. t-
Tests were performed to detect significant differences in expression between the iP and iNP 
samples.
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Reporter constructs were created to analyze the effects of three previously identified 
polymorphisms located in the 2nd intron, 3rd intron, and the 3′UTR (Bice et al., 1998; 
Larhammar et al., 1987) (Fig. 2). First, to amplify the regions encompassing these 
polymorphisms, three primer pairs were designed: Luc-1F and Luc-1R for the second intron, 
Luc-2F and Luc-2R for the third intron, and Luc-3F and Luc-3R for the 3′UTR (Table 1). 
Using iP and iNP genomic DNA, six fragments were amplified and ligated into the pCR2.1-
TOPO vector. Sequence analysis was then performed to confirm that there were no errors. 
The resulting TOPO constructs were digested with either BamHI or XbaI, depending on the 
desired site of insertion of each fragment into the pGL-3 Promoter vector (Promega, 
Madison, WI, USA). These sites were determined based on the location of each fragment in 
the NPY gene. The resulting fragments were gel-isolated and ligated into a pGL-3 Promoter 
vector that was either digested with BamHI or XbaI. Thus, the fragments encompassing the 
polymorphisms in the 2nd and 3rd introns were ligated into the pGL-3 Promoter vector in a 
site following the SV40 late poly(A) signal, while the 3′UTR fragments were ligated 
between the luciferase gene and the SV40 late poly(A) signal (Fig. 3). To determine 
fragment orientation, each fragment was amplified using either the fragment specific 
forward or reverse primer paired with Luc-4R, a primer specific to the pGL-3 Promoter 
vector. The constructs containing the correct orientation of each fragment were isolated 
using the EndoFree Plasmid Maxi Kit (Qiagen).
Transient transfection and luciferase assays
Human neuroblastoma SK-N-SH cells were cultured in Eagle’s Minimal Essential Medium 
containing 7.5% NaHCO3, 2 mM Glut-max, 0.1 mM non-essential amino acids, 1 mM 
pyruvate, 10% FBS (Invitrogen, Carlsbad, CA, USA) and were maintained at 37°C in a 
humidified 5% CO2 incubator. Twenty-four hours before transfection, 4.0×104 cells were 
plated into each well of a 24 well plate; 0.5 μg of each pGL-3 luciferase test plasmid was 
transfected per well using Tfx 50 reagent (Promega); 2.5 ng of CMV renilla vector (pRL-
CMV) was cotransfected with each pGL-3-luciferase test plasmid to serve as an internal 
control for transfection efficiency. Cells were incubated for 48 h, washed, and harvested 
using passive lysis buffer. Cell extracts were assayed for firefly and Renilla luciferase 
activities in a TD-20/20 Luminometer, using the Dual-Luciferase Reporter Assay System 
(Promega). Luciferase assays were performed three to six times in triplicate, using plasmids 
that were independently purified at least twice.
RESULTS
NPY exhibits reduced mRNA expression in alcohol-naive iP rats compared with iNP rats in 
multiple brain regions
To assess the endogenous difference in NPY mRNA expression between iP and iNP rats, 
discrete brain regions dissected from alcohol-naive iP and iNP rats were analyzed using 
qRT-PCR. NPY mRNA expression was observed at significantly decreased levels in the 
nucleus accumbens (P=0.006), the frontal cortex (P=0.04), the amygdala (P=0.0004), the 
hippocampus (P<0.00001), the caudate putamen (P=0.02), and the hypothalamus (P=0.02) 
in the iP rat (Fig. 1). The greatest difference in expression comparing iNP to iP was in the 
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hippocampus and caudate putamen (2.2-fold difference), and the smallest difference in 
expression was in the frontal cortex and hypothalamus (1.3-fold difference; Fig. 1).
Microsatellite marker D4Mit7 polymorphism reduced luciferase activity in vitro using SK-N-
SH cells
The microsatellite marker D4Mit7 is located in the 2nd intron of NPY. To determine the 
probable effects of the previously identified polymorphisms on NPY gene expression, PCR 
was employed to generate DNA fragments containing the polymorphisms in the 2nd intron 
(D4Mit7), 3rd intron and 3′UTR. The fragments containing the 2nd and 3rd intron 
polymorphisms were cloned into the pGL-3 Promoter luciferase vector downstream the 
SV40 late poly(A) signal, while the 3′UTR fragments were ligated between the luciferase 
gene and the SV40 late poly(A) signal (Fig. 2). All constructs were transiently transfected 
into SK-N-SH cells, which constitutively express the endogenous NPY gene. Luciferase 
expression was expressed in fold-change compared with the pGL-3 Promoter-luciferase 
(luc) construct (Fig. 3). The iP-(2nd intron)-luc construct defined by the D4Mit7 
microsatellite marker exhibited a significant decrease in expression in SK-N-SH cells 
compared with the iNP-(2nd intron)-luc construct (P<0.05). The 3rd intron-luc and the 
3′UTR-luc vectors did not significantly alter luciferase activity in SK-N-SH cells.
DISCUSSION
In this study, alcohol-naive iP rats exhibited a reduced level of NPY mRNA expression 
compared with iNP rats in the nucleus accumbens, frontal cortex, amygdala, hippocampus, 
caudate putamen, and hypothalamus. Three polymorphisms in the NPY gene were assessed 
for their functional significance in modulating NPY expression. In vitro expression analysis 
using neuroblastoma SK-N-SH cells yielded a significant decrease in expression of the iP-
(2nd intron)-luc construct compared with the iNP-(2nd intron)-luc construct (P<0.05). 
These results suggest that an endogenous decrease in NPY expression may be influencing 
the phenotypic decrease in NPY protein expression that has been previously observed in 
various brain regions when comparing P and NP rats.
The reduced level of NPY mRNA expression observed in alcohol-naive iP rats compared 
with iNP rats corroborated the previous evidence of a reduction in NPY protein levels in 
central nucleus of the amygdala, hippocampus, and the frontal cortex (Ehlers et al., 1998; 
Hwang et al., 1999). In contrast, iP animals exhibited significantly lower levels of NPY 
mRNA expression in the hypothalamus in the present study, whereas, in a previous study, 
higher levels of NPY immunoreactivity were detected in the paraventricular hypothalamic 
nucleus of P rats than NP rats (Hwang et al., 1999). Lack of correlation between mRNA and 
protein levels may have resulted from procedural differences between the two studies. In our 
study, the entire hypothalamus was dissected, whereas a very specific region of the 
hypothalamus was quantified in the immunohistochemistry studies. Lower levels of NPY 
mRNA have been documented in high alcohol drinking rats compared with the low alcohol 
drinking rats (Hwang et al., 1999). No difference in NPY mRNA expression was observed 
between NP rats compared with P rats (Caberlotto et al., 2001). Together, these data suggest 
that the NPY expression in the hypothalamus may not play a defining role in the modulation 
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of alcohol preference, whereas its expression in the amygdala, a region implicated in anxiety 
and the reinforcing properties of alcohol may be influential in the regulation of alcohol-
seeking behavior (Koob et al., 1998; Cowen et al., 2004).
In vitro expression analysis revealed a significant decrease in luciferase expression in iP-
(2nd intron)-luc construct compared with the iNP-(2nd intron)-luc, providing a potential 
mechanism for the reduced mRNA and protein expression. Furthermore, the functional 
insignificance of the 3′UTR polymorphism, a primary site for the regulation of mRNA 
stability (Nair and Menon, 2000; Wang and Kiledjian, 2000; Loflin and Lever, 2001), 
suggests that NPY expression is regulated at the transcriptional level. Although 
neuroblastoma cells do not fully reflect regulatory mechanisms underlying NPY expression 
in neuronal cells, they show that the D4Mit7 polymorphism is functional in a cell line that 
expresses NPY.
The reduced expression exhibited by one variant of the D4Mit7 polymorphism is consistent 
with the lower NPY mRNA and protein levels detected in discrete brain regions of the iP 
strain compared with the iNP strain. The polymorphism defined by the marker D4Mit7 is 
localized to a GC rich region, possibly involved in transcriptional regulation. Intronic 
polymorphisms have been associated with regulation of gene expression (Fiskerstrand et al., 
1999; Arnold et al., 2000; Bream et al., 2000; Agarwal et al., 2000). Thus, polymorphic 
regions, previously used as genetic markers, may function in regulating gene expression 
(Katsuki et al., 1996). It is postulated that these alternating purine-pyrimidine tracts form Z-
DNA (left-handed helices) or cruciform regions that influence gene expression, and some 
CA repeat sequences do exhibit moderate enhancer activities (Hamada et al., 1984). 
However, the difference in expression associated with the D4Mit7 polymorphism may not 
fully account for the observed expression difference in NPY detected between iP and iNP 
rats. Therefore, additional studies will be necessary to define the functional significance of 
additional polymorphisms discovered in the NPY gene. It is also possible that sequencing 
additional 5′region will identify other functional polymorphisms since regulatory elements 
can be located many kilobases upstream in the gene.
The inverse relationship between levels of NPY in various regions of the brain and alcohol 
consumption has been documented in previous literature (Badia-Elder et al., 2001; Thiele et 
al., 1998). However, the molecular mechanism of NPY remains to be elucidated even in the 
P and NP rats where the difference in NPY expression appears to be well defined (Ehlers et 
al., 1998; Hwang et al., 1999). This study has attempted to further characterize NPY 
expression in order to ultimately distinguish NPY expression as a primary source of the 
decrease in NPY protein expression observed in various brain regions between P and NP 
rats.
In conclusion, the effects of NPY levels on alcohol preference in the P and NP rats have 
been established in previous studies (Badia-Elder et al., 2001). This study provided evidence 
of decreased mRNA expression in several brain regions, including the nucleus accumbens, 
frontal cortex, amygdala, hippocampus, caudate putamen, and hypothalamus. The 
previously identified D4Mit7 marker polymorphism appeared functional, while the 3rd 
intron and 3′UTR polymorphisms produced no change in luc expression. All in all, these 
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results further implicated the regulation of NPY gene expression as a likely source for the 
difference in NPY levels detected between iP and iNP rats.
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NPY mRNA expression is decreased in alcohol-naive P rats compared with NP rats. qRT-
PCR analysis was utilized to compare the relative levels of NPY mRNA between alcohol-
naive iP and iNP rats in the nucleus accumbens, the frontal cortex, the amygdala, the 
hippocampus, the caudate putamen, and the hypothalamus. All values were determined 
using the standard curve method and compared with mRNA expression in the iP 
hypothalamus, which was arbitrarily designated 1. The graph depicts the mean±S.E.M. of 
the results from five independent iP and four independent iNP experiments performed in 
triplicate, using separate preparations of cDNA. Significant differences in regional NPY 
mRNA expression between iP and iNP rats was determined using the Student’s t-test. * 
P<0.05; ** P<0.0005.
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Polymorphisms identified in the NPY gene. Sequence analysis was previously performed on 
the NPY gene and identified three polymorphisms in the 2nd intron, 3rd intron and 3′UTR 
(Bice et al., 1998). (A) The diagram depicts the NPY gene. NPY’s four exons are 
represented with white boxes, while a black line depicts the intronic regions. The 
microsatellite marker D4Mit7 is represented with a black box. The three polymorphisms that 
have been identified in the NPY gene are labeled with arrows and their position relative to 
the translational start point (Tsp) that was designated +1. (B) Three polymorphisms are 
defined by their regional location in the NPY gene, their position relative to the Tsp (+1), 
and the sequence difference detected between iP and iNP rats.
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Functional importance of the NPY polymorphisms identified in the 2nd intron, 3rd intron, 
and 3′UTR. The Luc constructs were transiently transfected into SK-N-SH cells, and the 
resulting effect on luciferase expression was subsequently determined. SV40, luc+, and 
poly(A) denote the SV40 promoter, the luciferase gene, and the SV40 late poly(A) signal, 
respectively. The polymorphisms, located at +4666, +6871, and +7010, are noted in addition 
to the relative insertion site of each fragment into the pGL-3 Promoter vector. The activity 
of each construct was normalized to the internal control plasmid, pRL-CMV, and was 
expressed as fold change compared with the activity of the pGL-3 Promoter vector, which 
was designated as 1. The bars and fold change show the mean±S.E.M. of the results from 
seven independent transfection experiments performed in triplicate, using two different 
plasmid preparations. The significance of differences in the resulting mean values within 
and between multiple constructs was analyzed using ANOVA. An asterisk denotes a 
significant reduction in luc expression.
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